Boehringer Ingelheim Acquires AMAL Therapeutics, Significantly Enriching...
Business Wire India Acquisition adds key platform supporting Boehringer Ingelheim’s focus on patients with difficult-to-treat gastrointestinal and lung cancers AMAL’s first-in-class propri...